The Diagnostic Value of microRNA Expression Analysis in Detecting Intraductal Papillomas in Patients with Pathological Nipple Discharge.

biomarkers breast cancer ductoscopy miRNA nipple discharge

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Feb 2024
Historique:
received: 15 11 2023
revised: 30 01 2024
accepted: 01 02 2024
medline: 10 2 2024
pubmed: 10 2 2024
entrez: 10 2 2024
Statut: epublish

Résumé

Patients with pathological nipple discharge (PND) often undergo local surgical procedures because standard radiologic imaging fails to identify the underlying cause. MicroRNA (MiRNA) expression analysis of nipple fluid holds potential for distinguishing between breast diseases. This study aimed to compare miRNA expression levels between nipple fluids from patients with PND to identify possible relevant miRNAs that could differentiate between intraductal papillomas and no abnormalities in the breast tissue. Nipple fluid samples from patients with PND without radiological and pathological suspicion for malignancy who underwent a ductoscopy procedure were analyzed. We used univariate and multivariate regression analyses to identify nipple fluid miRNAs differing between pathologically confirmed papillomas and breast tissue without abnormalities. A total of 27 nipple fluid samples from patients with PND were included for miRNA expression analysis. Out of the 22 miRNAs examined, only miR-145-5p was significantly differentially expressed (upregulated) in nipple fluid from patients with an intraductal papilloma compared to patients showing no breast abnormalities (OR 4.76,

Identifiants

pubmed: 38339089
pii: ijms25031812
doi: 10.3390/ijms25031812
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Seher Makineli (S)

Department of Surgical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

Menno R Vriens (MR)

Department of Surgical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

Arjen J Witkamp (AJ)

Department of Surgical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

Paul J van Diest (PJ)

Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

Cathy B Moelans (CB)

Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

Classifications MeSH